H2 Histamine Receptor Blockade in the Treatment of Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial of Nizatidine : Alzheimer Disease & Associated Disorders

Journal Logo

Articles

H2 Histamine Receptor Blockade in the Treatment of Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial of Nizatidine

Carlson, Michelle C.; Tschanz, JoAnn T.**†; Norton, Maria C.**†; Welsh-Bohmer, Kathleen; Martin, Barbara K.§; Breitner, John C. S.*

Author Information
Alzheimer Disease & Associated Disorders 16(1):p 24-30, January 2002.

Abstract

© 2002 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid